ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,169 | +50.8% | 66,010 | +128.2% | 0.00% | – |
| Q2 2023 | $299,932 | -9.7% | 28,923 | +26.5% | 0.00% | – |
| Q4 2021 | $332,000 | -71.0% | 22,864 | -64.1% | 0.00% | -100.0% |
| Q3 2021 | $1,145,000 | -75.8% | 63,622 | -76.4% | 0.00% | -75.0% |
| Q2 2021 | $4,728,000 | +3481.8% | 269,255 | +285.9% | 0.00% | – |
| Q4 2019 | $132,000 | -82.6% | 69,769 | -90.1% | 0.00% | -100.0% |
| Q3 2019 | $758,000 | -48.3% | 701,465 | +4.8% | 0.00% | -50.0% |
| Q2 2019 | $1,466,000 | -86.8% | 669,259 | -63.9% | 0.00% | -85.7% |
| Q1 2019 | $11,099,000 | -34.1% | 1,852,869 | -18.7% | 0.01% | -39.1% |
| Q4 2018 | $16,837,000 | -12.7% | 2,278,364 | +71.6% | 0.02% | 0.0% |
| Q3 2018 | $19,277,000 | -23.9% | 1,327,583 | +4.6% | 0.02% | -30.3% |
| Q2 2018 | $25,340,000 | +16.8% | 1,268,915 | +2.5% | 0.03% | +10.0% |
| Q1 2018 | $21,695,000 | -14.0% | 1,238,286 | +21.0% | 0.03% | -14.3% |
| Q4 2017 | $25,230,000 | +7935.0% | 1,023,128 | +8315.3% | 0.04% | – |
| Q3 2017 | $314,000 | – | 12,158 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |